LINC01628

Across TCGA pan-cancer cohorts, LINC01628 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated LINC01628 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01628 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01628 expression acts as an unfavorable survival marker.

UCEC, BLCA, and KICH are the cancer types where LINC01628 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.652	0.878	.001	96	view →
BLCA	DFS	Tertile	All	0.140	0.627	<.001	72	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	63	view →
STAD	DFS	Tertile	All	0.138	0.720	<.001	54	view →
LUSC	OS	Tertile	II,III,IV	0.106	0.743	<.001	36	view →
ESCA	DFS	Tertile	III,IV	0.023	0.443	<.001	27	view →
ACC	DFS	Tertile	II,III,IV	0.226	0.725	.009	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

LINC01628–UCEC (OS)

Open the UCEC breakdown →